Boel Jonas, Andreasen Viggo, Jarløv Jens Otto, Østergaard Christian, Gjørup Ida, Bøggild Nina, Arpi Magnus
Department of Clinical Microbiology, Herlev Hospital, University of Copenhagen, Herlev, Denmark Department of Science, Systems and Models, Roskilde University, Roskilde, Denmark Capital Region Pharmacy, Herlev Hospital, Herlev, Denmark
Department of Science, Systems and Models, Roskilde University, Roskilde, Denmark.
J Antimicrob Chemother. 2016 Jul;71(7):2047-51. doi: 10.1093/jac/dkw055. Epub 2016 Apr 7.
We evaluated the effect of an antibiotic stewardship programme (ASP) on the use of antibiotics and resistance levels of Escherichia coli using a method that allowed direct comparison between an intervention hospital and a control hospital.
The study was conducted as a retrospective controlled interrupted time series (ITS) at two university teaching hospitals, intervention and control, with 736 and 552 beds, respectively. The study period was between January 2008 and September 2014. We used ITS analysis to determine significant changes in antibiotic use and resistance levels of E. coli. Results were directly compared with data from the control hospital utilizing a subtracted time series (STS).
Direct comparison with the control hospital showed that the ASP was associated with a significant change in the level of use of cephalosporins [-151 DDDs/1000 bed-days (95% CI -177, -126)] and fluoroquinolones [-44.5 DDDs/1000 bed-days (95% CI -58.9, -30.1)]. Resistance of E. coli showed a significant change in slope for cefuroxime [-0.13 percentage points/month (95% CI -0.21, -0.057)] and ciprofloxacin [-0.15 percentage points/month (95% CI -0.26, -0.038)].
The ASP significantly reduced the use of cephalosporins and fluoroquinolones, with concomitant decreasing levels of E. coli resistance to cefuroxime and ciprofloxacin. The same development was not observed at the control hospital.
我们采用一种能直接对比干预医院和对照医院的方法,评估了抗生素管理计划(ASP)对大肠杆菌抗生素使用及耐药水平的影响。
本研究作为一项回顾性对照中断时间序列(ITS)研究,在两所大学教学医院(干预医院和对照医院)开展,分别有736张和552张床位。研究时间段为2008年1月至2014年9月。我们使用ITS分析来确定抗生素使用及大肠杆菌耐药水平的显著变化。利用相减时间序列(STS)将结果与对照医院的数据直接对比。
与对照医院直接对比显示,ASP与头孢菌素使用水平的显著变化相关[-151限定日剂量/1000床日(95%可信区间-177,-126)]以及氟喹诺酮类药物使用水平的显著变化相关[-44.5限定日剂量/1000床日(95%可信区间-58.9,-30.1)]。大肠杆菌对头孢呋辛的耐药性斜率有显著变化[-0.13个百分点/月(95%可信区间-0.21,-0.057)],对环丙沙星的耐药性斜率也有显著变化[-0.15个百分点/月(95%可信区间-0.26,-0.038)]。
ASP显著减少了头孢菌素和氟喹诺酮类药物的使用,同时大肠杆菌对头孢呋辛和环丙沙星的耐药水平也随之降低。对照医院未观察到同样的变化。